Skip to main content

☰

Home
About
Research
Programs
Commercialization
Get Involved
Events

Home
About
Research
Programs
Commercialization
Get Involved
Events

About

About

Overview
What are Biologics?
Executive Committee
News
- In the Media

In the Media

UT researchers say they found an antibody that protects against all COVID-19 variants

KXAN

Here are some of the biggest medical advances in 2023

ScienceNews

A Truly Amazing Vaccine Breakthrough Is Hiding in Plain Sight

The Atlantic

UT Austin researchers make headway toward universal coronavirus treatments

KUT News

First RSV vaccine with UT ties expected to be available by next year

KXAN

University of Texas research initiative to advance development of biologic therapies

Austin American-Statesman

This UT Scientist Helped Spare Millions From COVID-19. Now He’s Unmasking Other Killer Viruses.

Texas Monthly

For decades, fear and failure in the hunt for an RSV vaccine. Now, success.

Washington Post

Cancer Institute grants $8.5 million to UT to further research

The Daily Texan

Biologics Market Players Evolving to New Heights in 2022 – Exclusive Report by Mordor Intelligence

Digital Journal

©

The University of Texas at Austin | Privacy Policy | Web Accessibility

Cockrell School of Engineering
College of Natural Sciences
Dell Medical School

Resources

Contact Us
News